PPC
MEDP icon

Park Place Capital’s Medpace MEDP Stock Holding History

Park Place Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Hold
208
– – 0.02% 303
2026
Q1 		$99.9K Hold
208
– – 0.02% 266
2025
Q4 		$117K Sell
208
-7
-3% -$3.97K 0.02% 235
2025
Q3 		$111K Sell
215
-58
-21% -$25.3K 0.02% 245
2025
Q2 		$87.7K Hold
273
– – 0.02% 277
2025
Q1 		$83.2K Hold
273
– – 0.02% 279
2024
Q4 		$90.7K Sell
273
-13
-5% -$4.41K 0.03% 281
2024
Q3 		$95.5K Buy
286
+27
+10% +$10.3K 0.03% 290
2024
Q2 		$107K Sell
259
-16
-6% -$6.34K 0.03% 267
2024
Q1 		$111K Sell
275
-22
-7% -$7.74K 0.04% 297
2023
Q4 		$91K Sell
297
-6
-2% -$1.62K 0.04% 327
2023
Q3 		$73.4K Hold
303
– – 0.02% 407
2023
Q2 		$72.8K Buy
303
+20
+7% +$4.15K 0.02% 424
2023
Q1 		$53.2K Sell
283
-13
-4% -$2.69K 0.01% 469
2022
Q4 		$63K Buy
+296
New +$59.1K 0.02% 451

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Park Place Capital's MEDP Position: Q2 2026 in Review

Park Place Capital held its Medpace (MEDP) position steady in Q2 2026 at 208 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #303.

Park Place Capital first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $117K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Park Place Capital held 208 shares of Medpace worth $110K as of Q2 2026.
  • Park Place Capital left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.02% of Park Place Capital's portfolio in Q2 2026, its #303 holding.
  • Park Place Capital first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Medpace position peaked at $117K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.